The treatment of Breast Adenocarcinoma & Hypoglycemia with vitamins

Breast Adenocarcinoma and Hypoglycemia: Mitamins custom make quality formulas for the treatment of Breast Adenocarcinoma & Hypoglycemia with vitamins. A Breast Adenocarcinoma & Hypoglycemia formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Breast Adenocarcinoma and Hypoglycemia

  • Amount Per Serving
    % DV
    Vitamin A
    2500
    IU
    50%
    Vitamin C
    300
    mg
    500%
    Vitamin D
    200
    IU
    50%
    Vitamin E
    200
    IU
    667%
    Thiamin
    50
    mg
    3333%
    Riboflavin
    50
    mg
    2941%
    Niacin
    100
    mg
    500%
    Vitamin B6
    50
    mg
    2500%
    Folate
    800
    mcg
    200%
    Vitamin B12
    50
    mcg
    833%
    Biotin
    50
    mcg
    17%
    Pantothenic Acid
    50
    mg
    500%
    Calcium
    200
    mg
    20%
    Magnesium
    100
    mg
    25%
    Zinc
    20
    mg
    133%
    Selenium
    100
    mcg
    143%
    Copper
    2
    mg
    100%
    Chromium
    100
    mcg
    83%
    Molybdenum
    50
    mcg
    67%
    Choline Bitartrate
    50
    mg
    *
    Inositol
    50
    mg
    *
    PABA
    50
    mg
    *
    Alpha Lipoic Acid
    50
    mg
    *
    Lactobacillus acidolphilus
    100
    mg
    *
    CoQ-10
    30
    mg
    *
    Flax Seed Powder
    50
    mg
    *
    Lecithin
    100
    mg
    *
    Lutein
    1000
    mcg
    *
  • Amount Per Serving
    % DV
    Lycopene
    3000
    mcg
    *
    MSM
    250
    mg
    *
    Astragalus Extract
    200
    mg
    *
    Bilberry Extract
    50
    mg
    *
    Bioflavonoid Concentrate
    100
    mg
    *
    Garlic Extract
    100
    mg
    *
    Ginkgo Extract
    40
    mg
    *
    American Ginseng Extract
    50
    mg
    *
    Eleuthero Extract
    100
    mg
    *
    Grape Seed Extract
    75
    mg
    *
    Green Tea Extract
    100
    mg
    *
    Maitake Extract
    50
    mg
    *
    Reishi Extract
    50
    mg
    *
    Shiitake Extract
    50
    mg
    *
    Quercetin
    100
    mg
    *
    L-Glutathione Reduced
    100
    mg
    *
    N-Acetyl L-Cysteine
    250
    mg
    *
    L-Arginine
    250
    mg
    *
    Amino Acid Mix
    50
    mg
    *
    Turmeric Extract
    50
    mg
    *
    Boswellia Serrata Extract
    100
    mg
    *
    Calcium D-Glucarate
    200
    mg
    *
    Indole-3-Carbinol
    100
    mg
    *
    Cordyceps Extract
    100
    mg
    *
    Ginger Extract
    100
    mg
    *
    Olive Extract
    100
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice
Breast Adenocarcinoma and Hypoglycemia
Monthly Cost: $80.92
Serving Size:4-5
30 Days Money Back Guarantee
100% Satisfaction Guarantee

Breast Adenocarcinoma and Hypoglycemia Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
Update This Formula
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
Rheumatoid Arthritis Patients Benefit From Meditation Therapy
A revered contemplative practice for centuries, meditation has recently inspired research into its therapeutic value for everything from anxiety disorders to heart attack prevention. A painful, progressive autoimmune disease, rheumatoid arthritis (RA) is associated with a high risk of depression -- double the risk of the healthy population, by conservative estimates -- and various forms of psychological distress.
Argenes Initiates Phase I Clinical Study Of ARG098 (Anti-Fas IgM Monoclonal Antibody), A Novel Therapeutics For Rheumatoid Arthritis, In Europe
Tokyo, Japan - Argenes, Inc. announce that it has started Phase I clinical study of the novel anti-rheumatoid arthritis (RA) agent ARG098 in patients with RA in Belgium and has administered to the first patient. The clinical study intends to evaluate the safety and tolerability of ARG098 into the knee joint cavity of patients with RA and examine its efficacy and pharmacokinetics.Efficacy of ARG098 on RA was found in the collaborative study with Santen Pharmaceutical Co., Ltd.
This information concerning the support of Breast Adenocarcinoma and Hypoglycemia treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Mitamins Logo
Home  Multi-Conditions formulas  Cancer & Chemo  Breast Adenocarcinoma  Breast Adenocarcinoma and Hypoglycemia
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments